- Asian Investment Desk
- Banking and Finance
- Banking Regulation
- Capital Markets
- Corporate and Commercial
- Corporate Compliance
- Energy
- Environmental
- ESG | Environmental, Social and Governance
- Fintech
- Fishery
- Forestry
- Immigration
- Infrastructure and Concessions
- Insurance and Reinsurance
- Intellectual Property
- International Trade and Customs
- Labor & Employment
- Life Sciences
- Maritime and Aviation
- Mergers and Acquisitions
- Mining
- Oil & Gas
- Privacy and Data Protection
- Project Development
- Project Finance
- Public Law
- Public Procurement
- Public Services Regulation
- Real Estate Investment
- Restructuring and Insolvency
- Tax
- Telecom, Media & Technology (TMT)
- Venture Capital and Entrepreneurship
- Water Resources and Sanitation
- Wealth Management
Asian Investment Desk
Banking and Finance
Banking Regulation
Capital Markets
Corporate and Commercial
Corporate Compliance
Energy
Environmental
ESG | Environmental, Social and Governance
Fintech
Fishery
Forestry
Immigration
Infrastructure and Concessions
Insurance and Reinsurance
Intellectual Property
International Trade and Customs
Labor & Employment
Life Sciences
Maritime and Aviation
Mergers and Acquisitions
Mining
Oil & Gas
Privacy and Data Protection
Project Development
Project Finance
Public Law
Public Procurement
Public Services Regulation
Real Estate Investment
Restructuring and Insolvency
Tax
Telecom, Media & Technology (TMT)
Venture Capital and Entrepreneurship
Water Resources and Sanitation
Wealth Management
Publication
Life Sciences Legal Product - May 2026
May 27, 2026
Life Sciences | Rare and/or Orphan Diseases (RODs) in Peru
Our Life Sciences team presents an update on the evolution of the regulatory framework for Rare and/or Orphan Diseases (RODs) in Peru through a timeline highlighting the key regulatory milestones, from the enactment of Law No. 29698 to the most recent regulatory amendment in May 2026, which updated the list applicable to these diseases.
